WallStSmart

Coherent Inc (COHR)vsNovanta Inc (NOVT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coherent Inc generates 542% more annual revenue ($6.29B vs $980.60M). NOVT leads profitability with a 5.5% profit margin vs 4.7%. COHR appears more attractively valued with a PEG of 0.92. COHR earns a higher WallStSmart Score of 52/100 (C-).

COHR

Buy

52

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 4.7Quality: 6.3
Piotroski: 5/9Altman Z: 1.53

NOVT

Hold

44

out of 100

Grade: D

Growth: 4.7Profit: 5.0Value: 4.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

COHRSignificantly Overvalued (-373.2%)

Margin of Safety

-373.2%

Fair Value

$47.27

Current Price

$272.04

$224.77 premium

UndervaluedFair: $47.27Overvalued
NOVTSignificantly Overvalued (-1143.0%)

Margin of Safety

-1143.0%

Fair Value

$11.41

Current Price

$117.65

$106.24 premium

UndervaluedFair: $11.41Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COHR4 strengths · Avg: 8.8/10
EPS GrowthGrowth
73.0%10/10

Earnings expanding 73.0% YoY

Market CapQuality
$51.06B9/10

Large-cap with strong market position

PEG RatioValuation
0.928/10

Growing faster than its price suggests

Revenue GrowthGrowth
17.5%8/10

17.5% revenue growth

NOVT0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

COHR4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

P/E RatioValuation
269.6x2/10

Premium valuation, high expectations priced in

NOVT4 concerns · Avg: 3.5/10
PEG RatioValuation
2.114/10

Expensive relative to growth rate

EPS GrowthGrowth
0.6%4/10

0.6% earnings growth

Return on EquityProfitability
5.2%3/10

ROE of 5.2% — below average capital efficiency

Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : COHR

The strongest argument for COHR centers on EPS Growth, Market Cap, PEG Ratio. Revenue growth of 17.5% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bull Case : NOVT

NOVT has a balanced fundamental profile.

Bear Case : COHR

The primary concerns for COHR are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 269.6x leaves little room for execution misses. Thin 4.7% margins leave little buffer for downturns.

Bear Case : NOVT

The primary concerns for NOVT are PEG Ratio, EPS Growth, Return on Equity. A P/E of 81.3x leaves little room for execution misses.

Key Dynamics to Monitor

COHR profiles as a growth stock while NOVT is a value play — different risk/reward profiles.

COHR carries more volatility with a beta of 1.91 — expect wider price swings.

COHR is growing revenue faster at 17.5% — sustainability is the question.

NOVT generates stronger free cash flow (5M), providing more financial flexibility.

Bottom Line

COHR scores higher overall (52/100 vs 44/100) and 17.5% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coherent Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.

Novanta Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Novanta Inc. designs, manufactures, markets and sells precision motion, vision and photonics components and subsystems to original equipment manufacturers in the medical and industrial markets worldwide. The company is headquartered in Bedford, Massachusetts.

Want to dig deeper into these stocks?